[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100433882":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":97,"collaborators":100,"id":106,"slug":107,"hasResults":108,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":19,"eligibilityCriteria":112,"healthyVolunteers":108,"sex":113,"minAge":114,"maxAge":115,"enrollmentInfo":116,"targetDuration":19,"studyType":119,"phases":120,"briefSummary":122,"conditions":123,"keywords":19,"overallStatus":38,"whyStopped":19,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":134},{"fullName":5,"class":6},"The Hospital for Sick Children","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Bright Ideas- CIN Training","The PSST will be delivered by a \"trainer\" in a minimum of three 30-minute to 1-hour sessions with a parent and patient (if developmentally appropriate).\n\nDuring the first session, the study team member will build rapport by understanding relevant personal background and medical information; introduce PSST and the Bright IDEAS paradigm; review the patients experience with nausea as reported in Phase 1 and at other times during treatment; promote problem-solving strategies and skills; and develop an anti-nausea action plan. During the second session, the trainer will discuss how well the prior action plan worked and reinforce successful outcomes or, if unsuccessful, return to the problem-solving steps to generate a new action plan. The third session will review progress on CINV control, assist in problem-solving as needed, and discuss how to continue to use the Bright IDEAS framework to resolve future issues with CINV or symptom management more broadly.",[12],"Behavioral: Bright Ideas - CIN Training",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","Bright Ideas - CIN Training","Bright IDEAS is a validated problem-solving skill training intervention.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Lee Dupuis, PhD","SickKids Research Institute","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","416-813-7762","lee.dupuis@sickkids.ca",{"name":31,"role":27,"phone":32,"phoneExt":33,"email":34},"Tadi Hondonga","416-813-7654","309971","Tadi.hondonga@sickkids.ca",[36,54,68,82],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Children's Hospital Los Angeles","RECRUITING","Los Angeles","California","90027","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-118.24368,34.05223,{"lat":48,"lon":47},[51],{"name":52,"role":27,"phone":19,"phoneExt":19,"email":53},"Lauren Guidry","lguidry@chla.usc.edu",{"facility":55,"status":38,"city":56,"state":57,"zip":58,"country":42,"countryCode":43,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Rutgers Cancer Institute","New Brunswick","New Jersey","08901",{"type":45,"coordinates":60},[61,62],-74.45182,40.48622,{"lat":62,"lon":61},[65],{"name":66,"role":27,"phone":19,"phoneExt":19,"email":67},"Katie Devine, PhD","katie.devine@rutgers.edu",{"facility":69,"status":38,"city":70,"state":71,"zip":72,"country":42,"countryCode":43,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Inova Children's Hospital","Falls Church","Virginia","22042",{"type":45,"coordinates":74},[75,76],-77.17109,38.88233,{"lat":76,"lon":75},[79],{"name":80,"role":27,"phone":19,"phoneExt":19,"email":81},"Robin Dulman","rdulman@psvcare.org",{"facility":83,"status":38,"city":84,"state":85,"zip":86,"country":87,"countryCode":88,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Hospital for Sick Children","Toronto","Ontario","M5G 1X8","Canada","CA",{"type":45,"coordinates":90},[91,92],-79.39864,43.70643,{"lat":92,"lon":91},[95],{"name":22,"role":27,"phone":32,"phoneExt":96,"email":29},"309355",{"type":24,"investigatorFullName":98,"investigatorTitle":99,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Lee Dupuis","Senior Associate Scientist",[101,103,105],{"name":102,"class":6},"Rutgers Cancer Institute of New Jersey",{"name":104,"class":6},"Inova Fairfax Hospital",{"name":37,"class":6},"100433882","bright-ideas---cin-feasibility-study-100433882",false,"NCT04929899","Bright Ideas - CIN Feasibility Study","Improving Chemotherapy-induced Nausea Control Through Bright Ideas®-CIN Training: a Feasibility Study in Children Receiving Oral Chemotherapy","Inclusion Criteria:\n\n* Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)\n* newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy\n* English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)\n* without physical or cognitive impairments that preclude use of the PeNAT\n* planned to receive PO 6-mercaptopurine\n* not planned to receive IV, IM, SC or IT chemotherapy or oral or IV corticosteroids during the 7-day study period","ALL","4 Years","18 Years",{"count":117,"type":118},75,"ESTIMATED","INTERVENTIONAL",[121],"NA","In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.",[124],"Acute Lymphoblastic Leukemia (ALL)","2025-01-28",{"date":127,"type":128},"2025-01-31","ACTUAL",{"date":130,"type":128},"2022-03-01",{"date":132,"type":118},"2025-06",{"name":5,"class":6},4]